chr3-37014493-T-C
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000249.4(MLH1):c.739T>C(p.Ser247Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,459,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★).
Frequency
Consequence
NM_000249.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459732Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 726310
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:2
The p.S247P variant (also known as c.739T>C), located in coding exon 9 of the MLH1 gene, results from a T to C substitution at nucleotide position 739. The serine at codon 247 is replaced by proline, an amino acid with similar properties. This alteration has been reported in multiple individuals whose colorectal tumors demonstrate high microsatellite instability and loss of MLH1 expression on immunohistochemistry in Lynch syndrome/HNPCC families meeting Amsterdam criteria (Ward R et al. J. Cancer Res. Clin. Oncol. 2002 Aug;128:403-11; Mangold E et al. J. Pathol. 2005 Dec;207:385-95; Hardt K et al. Fam. Cancer. 2011 Jun;10:273-84). Functional assays demonstrated reduced MMR activity and expression for p.S247P compared to wild-type MLH1 (Raevaara TE et al. Gastroenterology. 2005 Aug;129:537-49). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved through mammals but not in all available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
This missense variant replaces serine with proline at codon 247 in the MutS interacting domain of the MLH1 protein. Computational prediction tool suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold ≥0.7, PMID: 27666373). Functional studies have shown that this variant decreased protein expression, localization and impaired mismatch repair activity (PMID: 16083711, 21120944, 22736432). This variant has been reported in multiple individuals affected with colorectal cancer and Lynch syndrome/hereditary nonpolyposis colorectal cancer (HNPCC) (PMID: 12200596, 15849733, 16083711, 16216036, 18383312, 21404117, 22736432, 27435373, 31118792). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Pathogenic. -
Lynch syndrome Pathogenic:1
Multifactorial likelihood analysis posterior probability >0.99 -
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 247 of the MLH1 protein (p.Ser247Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of Lynch syndrome (PMID: 12200596, 15849733, 16083711, 16216036, 22736432, 27435373, 30521064; Invitae). Invitae’s Lynch syndrome clinical variant model, which takes into account the clinical and family history, age, sex, and reported ancestry of multiple individuals with this MLH1 variant, predicts that it is pathogenic with a positive predictive value of at least 99%. This is a validated machine learning model developed at Invitae that incorporates the clinical features of 1,370,736 individuals referred for testing at Invitae. ClinVar contains an entry for this variant (Variation ID: 90342). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is expected to disrupt MLH1 function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects MLH1 function (PMID: 16083711, 17594722). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at